The Investigational New Drug (IND) and New Drug ...
• Submission of an IND to study a marketed drug or biologic product not required when: – Product used in generally the same patient population and same manner for which the agent was approved (ie, will not substantially increase patient risk) – Study not intended to support approval of the new use or … ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- electronic submission of ind safety reports to fda adverse
- guidelines for investigational new drugs ind requirements
- investigational new drug application
- the investigational new drug ind and new drug
- appendix 1 ind checklist ind submissions to fda
- what fda expects in your submissions biologics drugs
- investigational new drug ind submission checklist